4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-23-006524
Head of Pharm Ops and Tech gave up 233 shares (to pay taxes)
- Head of Pharm Ops and Tech acquired 480 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-17 | Option exercise | +480 | 5,579.29 | D: show line 1 in the form | ||
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-17 | Shares withheld for taxes | −233 | $278.38 | $64,863 | 5,099.29 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-17 | Option exercise · Restricted Stock Unit | −480 | 1,334 | D: show line 3 in the form | ||
| Murphy Nicole Head of Pharm Ops and Tech | 2023-02-17 | Other disposition · Restricted Stock Unit | −426 | 908 | D: show line 4 in the form |
Loading xslF345X03/form4.xml…